Axon Enterprise, Inc. (NASDAQ:AXON) Insider Sells $646,326.45 in Stock

Axon Enterprise, Inc. (NASDAQ:AXON - Get Free Report) insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the sale, the insider now directly owns 124,243 shares of the company's stock, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Axon Enterprise Stock Down 1.2 %

Shares of AXON traded down $7.45 during midday trading on Thursday, reaching $623.80. 525,778 shares of the company were exchanged, compared to its average volume of 613,006. Axon Enterprise, Inc. has a 1-year low of $241.72 and a 1-year high of $698.67. The stock has a 50-day moving average price of $574.89 and a 200-day moving average price of $426.30. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market cap of $47.57 billion, a price-to-earnings ratio of 161.19, a P/E/G ratio of 14.19 and a beta of 1.01.

Analyst Ratings Changes

A number of brokerages have issued reports on AXON. Morgan Stanley raised Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. JMP Securities raised their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a research report on Thursday, October 31st. Needham & Company LLC upped their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. Northland Securities increased their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a research note on Monday, November 11th. Finally, The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. One analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $488.67.

Hedge Funds Weigh In On Axon Enterprise

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Insigneo Advisory Services LLC grew its position in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after acquiring an additional 22 shares during the last quarter. Menard Financial Group LLC boosted its stake in Axon Enterprise by 0.8% during the 3rd quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock valued at $1,204,000 after purchasing an additional 24 shares in the last quarter. PFG Investments LLC boosted its stake in Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company's stock valued at $1,547,000 after buying an additional 25 shares in the last quarter. Gladstone Institutional Advisory LLC boosted its position in shares of Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company's stock valued at $656,000 after purchasing an additional 26 shares in the last quarter. Finally, Mather Group LLC. grew its position in Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company's stock worth $303,000 after buying an additional 27 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.